Neuropsychiatry and Cognition in SCA3/MJD

Spinocerebellar ataxia 3

Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia Repetitive Transcranial Magnetic Stimulation in SCA3 Patients STRIDES – a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 Neuropsychiatry and Cognition in SCA3/MJD Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD – BIGPRO Study Astrocytes Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3 Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3 Hong Kong Spinocerebellar Ataxias Registry Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias Identification of Biomarkers in Spinocerebellar Ataxia 3 Machado-Joseph Disease in Israel Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 Clinical Trial Readiness for SCA1 and SCA3 Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3